ZA200203178B - New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. - Google Patents

New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Info

Publication number: ZA200203178B
Authority: ZA; South Africa
Prior art keywords: beta; new combination; adreno; receptor antagonist; receptor agonist
Prior art date: 1999-11-03

Application number

ZA200203178A

Other languages

English (en)

Inventor

Jan Trofast

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2002-04-22

Publication date

2003-07-22

2002-04-22 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-07-22 Publication of ZA200203178B publication Critical patent/ZA200203178B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA200203178A 1999-11-03 2002-04-22 New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist. ZA200203178B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9903995A SE9903995D0 (sv)	1999-11-03	1999-11-03	New combination

Publications (1)

Publication Number	Publication Date
ZA200203178B true ZA200203178B (en)	2003-07-22

Family

ID=20417605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200203178A ZA200203178B (en)	1999-11-03	2002-04-22	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.

Country Status (13)

Country	Link
EP (1)	EP1242065A1 (xx)
JP (1)	JP2003513037A (xx)
KR (1)	KR20020050254A (xx)
CN (1)	CN1387431A (xx)
AU (2)	AU1321401A (xx)
BR (1)	BR0015172A (xx)
CA (1)	CA2388657A1 (xx)
IL (1)	IL149365A0 (xx)
MX (1)	MXPA02004334A (xx)
NO (1)	NO20022103D0 (xx)
SE (1)	SE9903995D0 (xx)
WO (2)	WO2001032166A1 (xx)
ZA (1)	ZA200203178B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
AR040962A1 (es) *	2002-08-09	2005-04-27	Novartis Ag	Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
JP2007531743A (ja) *	2004-04-05	2007-11-08	セプラコアインコーポレーテッド	他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール
ES2245612B1 (es) *	2004-06-29	2007-08-16	Universidad De Barcelona	Nuevo uso terapeutico del formoterol.
CN101128196B (zh) *	2005-03-16	2013-01-02	Meda制药有限及两合公司	用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
JP2014518203A (ja) *	2011-06-06	2014-07-28	キエスィファルマチェウティチエス．ピー．エー．	ホスホジエステラーゼ阻害剤としての１−フェニル−２−ピリジニルアルキルアルコール誘導体
AR093796A1 (es) *	2012-12-05	2015-06-24	Chiesi Farm Spa	Derivados del alcohol 1-fenil-2-piridinil alquilico como inhibidores de la fosfodiesterasa
JP5846185B2 (ja)	2013-11-21	2016-01-20	大日本印刷株式会社	貫通電極基板及び貫通電極基板を用いた半導体装置
PT109030B (pt) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	Preparação de partículas inaláveis de zafirlucaste

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604752D0 (sv) *	1996-12-20	1996-12-20	Astra Ab	Formulation and use
TR199902242T2 (xx) *	1997-03-13	1999-12-21	Merck & Co., Inc.	Kinolin l�kotrien antagonistleri.
SE9704644D0 (sv) *	1997-12-12	1997-12-12	Astra Ab	New use

1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/xx unknown
2000
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/pt not_active Application Discontinuation
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en not_active Ceased
- 2000-10-27 IL IL14936500A patent/IL149365A0/xx unknown
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Ceased
- 2000-10-27 CN CN00815363A patent/CN1387431A/zh active Pending
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/es unknown
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/ko not_active Withdrawn
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/ja active Pending
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/xx unknown
- 2002-05-02 NO NO20022103A patent/NO20022103D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20022103L (no)	2002-05-02
BR0015172A (pt)	2002-06-18
AU1321401A (en)	2001-05-14
MXPA02004334A (es)	2002-11-07
SE9903995D0 (sv)	1999-11-03
WO2001032166A1 (en)	2001-05-10
KR20020050254A (ko)	2002-06-26
AU1652601A (en)	2001-05-14
JP2003513037A (ja)	2003-04-08
EP1242065A1 (en)	2002-09-25
NO20022103D0 (no)	2002-05-02
CN1387431A (zh)	2002-12-25
WO2001032163A1 (en)	2001-05-10
IL149365A0 (en)	2002-11-10
CA2388657A1 (en)	2001-05-10

Publication	Publication Date	Title
IL137990A0 (en)	2001-10-31	A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AP2000001916A0 (en)	2000-09-30	2-Adrenergic receptor agonists
ZA985678B (en)	2000-01-10	1-amino-alkylcyclohexane NMDA receptor antagonists.
IL139913A0 (en)	2002-02-10	Neuropeptide y5 receptor antagonists
EP1105389A4 (en)	2001-10-17	INTEGRIN RECEPTOR ANTAGONISTS
AU775774C (en)	2005-05-19	Peroxisome proliferator-activated receptor agonist
ZA200203178B (en)	2003-07-22	New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist.
ZA200100978B (en)	2002-02-05	Muscarinic agonists and antagonists.
EP1061921A4 (en)	2005-03-30	VITRONECTIN RECEPTOR ANTAGONIST
IL137930A0 (en)	2001-10-31	Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as a dopamine d4 receptor antagonists
AU5861900A (en)	2001-01-02	Receptor agonists and antagonists
AU6230698A (en)	1998-09-18	Dopamine d4 receptor antagonist
EP1102587A4 (en)	2003-03-12	vitronectin receptor antagonists
ZA200301162B (en)	2004-05-12	Gem-substituted alpha V beta 3 integrin antagonists.
ZA995029B (en)	2001-02-05	Estrogen agonists/antagonists.
PL351546A1 (en)	2003-05-05	1,5−benzodiazepine derivatives as cck−a receptor agonists
AU5234899A (en)	2000-02-21	Alpha 1a adrenergic receptor antagonists
AU2003202455A1 (en)	2003-06-12	A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
ZA200004561B (en)	2001-11-30	β 2-adrenergic receptor agonists.
ZA991884B (en)	1999-09-10	Vitronectin receptor antagonists.
HK1035319A (en)	2001-11-23	Vitronectin receptor antagonists
HK1038180A (en)	2002-03-08	Vitronectin receptor antagonists
ZA9610690B (en)	1997-10-29	Integrin receptor antagonists.
ZA978798B (en)	1998-04-02	Vitronectin receptor antagonists.
HK1031865A (en)	2001-06-29	Neuropeptide y5 receptor antagonists